Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis (2021)

First Author: Antonelou M

Attributed to: MICA: Investigating the role of myeloperoxidase as a key mediator of renal damage in crescentic glomerulonephritis and reno-cardiac disease funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Scandinavian Journal of Rheumatology

Issue: 2

ISSN: 0300-9742